Total Payments
$1,619
2024 Payments
$581.68
Companies
24
Transactions
79
Medicare Patients
679
Medicare Billing
$124,799
Payment Breakdown by Category
Food & Beverage$1,619 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,619 | 79 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $286.39 | 11 | $0 (2024) |
| AbbVie Inc. | $161.48 | 12 | $0 (2023) |
| PFIZER INC. | $148.10 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $141.20 | 8 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $130.50 | 3 | $0 (2024) |
| Lilly USA, LLC | $76.24 | 4 | $0 (2024) |
| EMD Serono, Inc. | $75.87 | 6 | $0 (2018) |
| ARGENX US, INC. | $75.35 | 3 | $0 (2024) |
| SK Life Science, Inc. | $73.41 | 3 | $0 (2024) |
| CSL Behring | $55.21 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $581.68 | 26 | UCB, Inc. ($181.98) |
| 2023 | $749.43 | 36 | AbbVie Inc. ($137.76) |
| 2022 | $173.30 | 9 | EISAI INC. ($30.41) |
| 2020 | $20.45 | 1 | CSL Behring ($20.45) |
| 2018 | $75.87 | 6 | EMD Serono, Inc. ($75.87) |
| 2017 | $18.52 | 1 | Avanir Pharmaceuticals, Inc. ($18.52) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/10/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: AMANTADINE | ||||||
| 07/18/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $37.67 | General |
| Category: Neurology | ||||||
| 07/18/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $34.76 | General |
| Category: Immunology | ||||||
| 06/27/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Rare Disease | ||||||
| 06/26/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Immune | ||||||
| 06/21/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Adenosine A2A Receptors | ||||||
| 06/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Neurology | ||||||
| 06/13/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/12/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Neurology | ||||||
| 06/12/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Neurology | ||||||
| 06/05/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Neuroscience | ||||||
| 06/01/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug), VYVGART | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Neurology | ||||||
| 05/07/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: AMANTADINE | ||||||
| 05/06/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $23.73 | General |
| Category: NEUROLOGY | ||||||
| 04/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: PAIN | ||||||
| 04/27/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Neuroscience | ||||||
| 04/26/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Neurology | ||||||
| 04/24/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Neurology | ||||||
| 04/12/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Neurology | ||||||
| 04/11/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $37.93 | General |
| Category: Neurology | ||||||
| 03/20/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $19.08 | General |
| 03/15/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $33.49 | General |
| Category: Neurology | ||||||
| 03/13/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Neuroscience | ||||||
| 03/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Neurology | ||||||
| 02/13/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 493 | 572 | $223,391 | $92,687 |
| 2022 | 6 | 186 | 204 | $77,393 | $32,112 |
Total Patients
679
Total Services
776
Medicare Billing
$124,799
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2023 | 119 | 120 | $79,560 | $39,763 | 50.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 104 | 130 | $34,840 | $16,946 | 48.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 79 | 79 | $25,912 | $12,375 | 47.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 63 | 66 | $17,713 | $8,974 | 50.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 45 | 85 | $14,960 | $7,959 | 53.2% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Facility | 2023 | 66 | 69 | $45,747 | $4,621 | 10.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 23 | $4,659 | $2,050 | 44.0% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2022 | 32 | 32 | $21,952 | $11,220 | 51.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 45 | 45 | $15,300 | $7,770 | 50.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 30 | $8,940 | $4,635 | 51.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 39 | $6,045 | $3,141 | 52.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 21 | $5,838 | $3,049 | 52.2% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Facility | 2022 | 26 | 26 | $17,836 | $1,798 | 10.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 11 | 11 | $1,482 | $499.62 | 33.7% |
About Dr. Avinash Sagi, M.D
Dr. Avinash Sagi, M.D is a Epilepsy healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2016. The National Provider Identifier (NPI) number assigned to this provider is 1932552130.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Avinash Sagi, M.D has received a total of $1,619 in payments from pharmaceutical and medical device companies, with $581.68 received in 2024. These payments were reported across 79 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,619).
As a Medicare-enrolled provider, Sagi has provided services to 679 Medicare beneficiaries, totaling 776 services with total Medicare billing of $124,799. Data is available for 2 years (2022–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Epilepsy
- Other Specialties Neurology, Internal Medicine
- Location Boston, MA
- Active Since 07/22/2016
- Last Updated 07/11/2022
- Taxonomy Code 2084E0001X
- Entity Type Individual
- NPI Number 1932552130
Products in Payments
- Fintepla (Drug) $170.14
- NURTEC ODT (Drug) $145.99
- KESIMPTA (Drug) $141.20
- SOLIRIS (Biological) $87.97
- UBRELVY (Drug) $77.47
- AMYVID (Drug) $76.24
- Rebif (Biological) $75.87
- BOTOX (Biological) $70.74
- Nayzilam (Drug) $64.50
- Hizentra (Biological) $55.21
- VYVGART HYTRULO (Drug) $54.19
- Gocovri (Drug) $46.88
- ULTOMIRIS (Biological) $42.53
- INFINITY (Device) $42.44
- BAFIERTAM (Drug) $38.51
- Briviact (Drug) $31.68
- Fycompa (Drug) $30.41
- VALTOCO (Drug) $30.13
- Nourianz (Drug) $28.99
- AUBAGIO (Drug) $25.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Epilepsy Doctors in Boston
Rachel Hirschberger, M.d., M.p.h, M.D., M.P.H
Epilepsy — Payments: $816.11
Epilepsy $816.11
Dr. Jennifer Gettings, Md, MD
Epilepsy — Payments: $107.08
Epilepsy $107.08
Jason You, Md, Phd, MD, PHD
Epilepsy — Payments: $12.67
Epilepsy $12.67
Ellen Bubrick, M.d, M.D
Epilepsy
Epilepsy
Dr. Felixe Pelletier, Md, MD
Epilepsy
Epilepsy
Dr. Alexander Dudley, Mb Bch Bao, MB BCH BAO
Epilepsy
Epilepsy